加拿大安大略省2015年消除期麻疹控制成本效果分析
在加拿大已消除麻疹且安大略省免疫覆盖率高的背景下,该研究从医疗付费方角度构建决策分析模型,比较2015年实际疫情暴发应对策略与假设的「改良应对」策略。结果显示,暴发应对以1213491加元(861579欧元)成本预防了16例相关病例,增量成本效果比为每获得一个QALY需739063加元(524735欧元),超过常用成本效果阈值。
要点
- 安大略省2015年麻疹暴发应对的增量成本效果比为每QALY 739063加元,超过50000加元/QALY的常用阈值。
- 要达到常用成本效果阈值,暴发应对需预防94例麻疹病例,而实际仅预防16例。
- 敏感性分析结果稳健,但结论需与提高疫苗覆盖率和维持消除状态的获益相平衡。
核心结论
- 安大略省麻疹暴发应对超出一般可接受的成本效果阈值,从医疗付费方角度看可能并非公共卫生资源的最有效利用。
研究设计与样本
- 决策分析模型,比较安大略省基于2015年实际暴发数据的麻疹遏制策略与假设的「改良应对」策略(假设应对成本为10%、减少病例和接触者追踪、无暴发相关疫苗接种)。
- 数据来源于地方和省级行政及实验室数据以及同行评议文献参数,短期和长期健康结局、质量调整生命年(QALY)和成本按1.5%贴现,并进行单因素和双因素敏感性分析。
主要发现
- 2015年安大略省暴发共16例麻疹病例和估计3369名接触者。
- 预测模型显示暴发应对以1213491加元(861579欧元)成本预防了16例暴发相关病例。
- 暴发应对相比改良应对的增量成本效果比为每获得一个QALY需739063加元(524735欧元)。
- 为达到常用成本效果阈值每QALY 50000加元(35500欧元),暴发应对需预防94例麻疹病例。
- 敏感性分析中 findings 稳健。
关键数值与推荐
- 增量成本效果比:每QALY 739063加元(524735欧元)。
- 常用成本效果阈值:每QALY 50000加元(35500欧元)。
- 达到阈值所需预防病例数:94例。
临床怎么用
- 从医疗付费方角度,安大略省麻疹暴发应对可能不是最具成本效果的公共卫生资源使用方式。
- 决策时应权衡暴发应对成本与提高疫苗覆盖率、维持消除状态的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundGiven that measles is eliminated in Canada and measles immunisation coverage in Ontario is high, it has been questioned whether Ontario's measles outbreak response is worthwhile.AimOur objective was to determine cost-effectiveness of measles containment protocols in Ontario from the healthcare payer perspective.MethodsWe developed a decision-analysis model comparing Ontario's measles containment strategy (based on actual 2015 outbreak data) with a hypothetical 'modified response'. The modified scenario assumed 10% response costs with reduced case and contact tracing and no outbreak-associated vaccinations; it was based on local and provincial administrative and laboratory data and parameters from peer-reviewed literature. Short- and long-term health outcomes, quality-adjusted life years (QALYs) and costs discounted at 1.5%, were estimated. We conducted one- and two-way sensitivity analyses.ResultsThe 2015 outbreak in Ontario comprised 16 measles cases and an estimated 3,369 contacts. Predictive modelling suggested that the outbreak response prevented 16 outbreak-associated cases at a cost of CAD 1,213,491 (EUR 861,579). The incremental cost-effectiveness ratio was CAD 739,063 (EUR 524,735) per QALY gained for the outbreak response vs modified response. To meet the commonly accepted cost-effectiveness threshold of CAD 50,000 (EUR 35,500) per QALY gained, the outbreak response would have to prevent 94 measles cases. In sensitivity analyses, the findings were robust.ConclusionsOntario's measles outbreak response exceeds generally accepted cost-effectiveness thresholds and may not be the most efficient use of public health resources from a healthcare payer perspective. These findings should be balanced against benefits of increased vaccine coverage and maintaining elimination status.
引用
- Ramsay LC, Crowcroft NS, Thomas S, et al. Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015. Euro Surveill. 2019. PMID: 30892178. doi:10.2807/1560-7917.ES.2019.24.11.1800370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。